Publications by authors named "Alex Teule"

Claim this Profile
C
Cabozantinib plus Atezolizumab in Advanced, Progressive Endocrine Malignancies: A Multicohort, Basket, Phase II Trial (CABATEN/GETNE-T1914).
Jaume Capdevila, Jorge Hernando, Javier Molina-Cerrillo, Marta Benavent Viñuales, Rocio Garcia-Carbonero

Clin Cancer Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized study of 2 risk assessment models for individualized breast cancer risk estimation.
Adrià López-Fernández, Laura Duran-Lozano, Guillermo Villacampa, Mónica Pardo, Eduard Pérez

J Natl Cancer Inst· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pneumomediastinum as an Early Manifestation in Birt-Hogg-Dubé Syndrome.
Bruno S Silva, Sergio Alarcón-Sisamón, Guadalupe Bermudo, Santiago Bolívar, Belen Del Río, Alex Teule

Arch Bronconeumol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TP53 germline testing and hereditary cancer: how somatic events and clinical criteria affect variant detection rate.
Paula Rofes, Carmen Castillo-Manzano, Mireia Menéndez, Álex Teulé, Sílvia Iglesias

Genome Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Everolimus Through Plasmatic Concentrations in Cancer Patients: Prospective Longitudinal Observational Multicentric Study (DIANA-1 Project).
Eduard Fort-Casamartina, Sonia Pernas, Sara Otero, Paula Mate, Núria Gonzalo

J Clin Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab plus platinum-doublet chemotherapy in treatment-naive patients with advanced grade 3 Neuroendocrine Neoplasms of gastroenteropancreatic or unknown origin: The multicenter phase 2 NICE-NEC trial (GETNE-T1913).
Maria Carmen Riesco-Martinez, Jaume Capdevila, Vicente Alonso, Paula Jimenez-Fonseca, Alex Teule

Nat Commun· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carcinoid crisis: The challenge is still there.
Fernando Guerrero-Pérez, Inmaculada Peiró, José L Vercher-Conejero, Alex Teulé, Carles Villabona

Endocrinol Diabetes Nutr (Engl Ed)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Sex differences on multikinase inhibitors toxicity in patients with advanced gastroenteropancreatic neuroendocrine tumours" [Eur J Cancer 188 (2023) 39-48].
Jorge Hernando, Maria Roca-Herrera, Alejandro García-Álvarez, Eric Raymond, Philippe Ruszniewski, Alex Teule

Eur J Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is long-term follow-up solely by imaging tests safe in non-operated pancreatic neuroendocrine tumors?
Daniela Polette, Juli Busquets, Lluis Secanella Medayo, Maria Sorribas Grifell, Núria Peláez Serra

Rev Esp Enferm Dig· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of Homologous Recombination Deficiency Among Patients With Germline RAD51C/D Breast or Ovarian Cancer.
Sara Torres-Esquius, Alba Llop-Guevara, Sara Gutiérrez-Enríquez, Marcel Romey, Àlex Teulé

JAMA Netw Open· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological basis of extensive pleiotropy between blood traits and cancer risk.
Miguel Angel Pardo-Cea, Xavier Farré, Anna Esteve, Joanna Palade, Roderic Espín

Genome Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer Risks Associated With Pathogenic Variants: Maximum Likelihood Analysis of Extended Pedigrees for Diagnosis of First Cancers Beyond the Li-Fraumeni Syndrome Spectrum.
Cristina Fortuno, Bing-Jian Feng, Courtney Carroll, Giovanni Innella, Wendy Kohlmann

JCO Precis Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomically matched therapy in refractory colorectal cancer according to ESMO Scale for Clinical Actionability of Molecular Targets: experience of a comprehensive cancer centre network.
Núria Mulet Margalef, Carmen Castillo, Miguel Mosteiro, Xavier Pérez, Susana Aguilar

Mol Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex differences on multikinase inhibitors toxicity in patients with advanced gastroenteropancreatic neuroendocrine tumours.
Jorge Hernando, Maria Roca-Herrera, Alejandro García-Álvarez, Eric Raymond, Philippe Ruszniewski, Alex Teule

Eur J Cancer· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mosaicism in PTEN-new case and comment on the literature.
Paula Rofes, Álex Teulé, Lídia Feliubadaló, Mònica Salinas, Raquel Cuesta

Eur J Hum Genet· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores.
Daniel R Barnes, Valentina Silvestri, Goska Leslie, Lesley McGuffog, Joe Dennis

J Natl Cancer Inst· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ectopic Cushing's syndrome due to thymic neuroendocrine tumours: a systematic review.
Fernando Guerrero-Pérez, Inmaculada Peiró, Agustina Pia Marengo, Alex Teulé, José Carlos Ruffinelli

Rev Endocr Metab Disord· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sunitinib and Evofosfamide (TH-302) in Systemic Treatment-Naïve Patients with Grade 1/2 Metastatic Pancreatic Neuroendocrine Tumors: The GETNE-1408 Trial.
Enrique Grande, Cristina Rodriguez-Antona, Carlos López, Teresa Alonso-Gordoa, Marta Benavent

Oncologist· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant.
Inge M M Lakeman, Alexandra J van den Broek, Juliën A M Vos, Daniel R Barnes, Julian Adlard

Genet Med· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Dueñas et al. Assessing Effectiveness of Colonic and Gynecological Risk Reducing Surgery in Lynch Syndrome Individuals. 2020, , 3419.
Nuria Dueñas, Matilde Navarro, Àlex Teulé, Ares Solanes, Mònica Salinas

Cancers (Basel)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.
Juliette Coignard, Michael Lush, Jonathan Beesley, Tracy A O'Mara, Joe Dennis

Nat Commun· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.
Juliette Coignard, Michael Lush, Jonathan Beesley, Tracy A O'Mara, Joe Dennis

Nat Commun· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Pathogenic Variants are Associated with Triple-Negative Breast Cancer in a Spanish Hereditary Breast and Ovarian Cancer Cohort.
Paula Rofes, Jesús Del Valle, Sara Torres-Esquius, Lídia Feliubadaló, Agostina Stradella

Genes (Basel)· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ERCC3, a new ovarian cancer susceptibility gene?
Agostina Stradella, Jesús Del Valle, Paula Rofes, Gardenia Vargas-Parra, Mónica Salinas

Eur J Cancer· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing Effectiveness of Colonic and Gynecological Risk Reducing Surgery in Lynch Syndrome Individuals.
Nuria Dueñas, Matilde Navarro, Àlex Teulé, Ares Solanes, Mònica Salinas

Cancers (Basel)· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis